We are currently reviewing cases where people have suffered health problems due to their ingestion of the diabetes drug Avandia (rosiglitazone). This dangerous drug is manufactured by Glaxo Smith Kline and was developed to help control blood sugar levels in adults with Type 2 Diabetes.

Avandia was initially approved by the Federal Drug Administration in 1999. Since its approval, Avandia has been linked to the following severe side-effects:

• elevated lipid levels
•  edema
•  congestive heart failure
• heart attacks
• death

Because of the many reports of problems, in May of 2007 the FDA issued a safety alert for heart attacks and cardiovascular events. In August of 2007, the FDA made Glaxo Smith Kline issue a Black Box Warning about Congestive Heart Failure, which is a vary serious warning aimed at informing the public and prescribing doctors of problems associated with the drug. The FDA made the manufacturer add a Black Box Warning for Myocardial Infarctions (heart attacks) in November of 2007. Additionally, several health insurance companies have removed this dangerous drug from their formularies, which means that they are no longer covered under those particular insurance plans.

Clearly, the FDA has recognized that there are many problems with this drug.  Our firm's experience tells us that there will eventually be more warnings, and possibly an outright withdrawal of Avandia from the market as more adverse reactions are discovered or related to the drug.

If you have suffered a heart attack or have a loved one who had a cardiac-related death while taking Avandia (for at least a month), then please give our office a call to discuss your options: 817-294-1900 or you can Contact Us Online.